2 COVID-19 ASX shares that could be buys 20 September 2021 fool.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com.au Daily Mail and Mail on Sunday newspapers.
There are a group of
S&P/ASX 200 Index(ASX: XJO) shares that continue to increase their dividend every year for investors.
Plenty of businesses previously known for paying dividends have reduced their payment during the last 18 months. Businesses like
Sydney Airport Holdings Pty Ltd (ASX: SYD) and
Transurban Group (ASX: TCL) all implemented reductions.
But these two continued the increases:
Sonic is one of the largest pathology healthcare businesses in the world with operations in ANZ, North America and Europe.
It is playing a very important part in the COVID-19 pandemic where it has performed millions of tests. That work continues, particularly in locations where COVID-19 infections are rising (with the Delta variant).
What’s next for the Cochlear share price?
A recent update from leading fund manager Wilson Asset Management (WAM) said that “recent data points suggest Cochlear continues to benefit from market share gains as a result of competitor Advanced Bionics … announcing a recall of some of its cochlear implant devices in February 2020”.
“Additionally, Cochlear remains a clear winner of the reopening trade and recent feedback from US audiologists suggest cochlear implant patient numbers are strongly above pre-coronavirus levels”.
The commentary from WAM bodes well with the solid year-to-date performance of the Cochlear share price.
Should you invest $1,000 in Cochlear right now?
Clinical Laboratory Tests Market Size 2021 Is Poised To Expand High CAGR By 2028
tusharJuly 10, 2021 Clinical Laboratory Tests Market
The global clinical laboratory tests market is driven by high prevalence of diseases, such as cardiovascular and neurological diseases, rise in geriatric population, development of technologically advanced products, such as biochips and microarrays, and surge in healthcare expenditure. Moreover, preference for preventive medicine, shorter hospital stay, and high demand for integrated analytical systems fuel the market growth. However, control of the FDA over laboratory-based tests delays the launch of new products and lack of skilled professionals in clinics based in emerging economies hamper this growth.
Worldwide Clinical Laboratory Services Industry to 2026 - by Type Service Provider and Region prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.